Sapir Alex has filed 5 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 650000 shares of Fulcrum Therapeutics, Inc. ($FULC) on February 02, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | Fulcrum Therapeutics, Inc. | $FULC | Sapir Alex | See Remarks | A | Stock option - Right to Buy | 650000 | $0.00 | 650,000.0000 | 62,597,000 | 9999.99% | 1.04% |
| Jan. 24, 2025 | Fulcrum Therapeutics, Inc. | $FULC | Sapir Alex | See Remarks | A | Stock option - Right to Buy | 582000 | $0.00 | 582,000.0000 | 61,984 | 9999.99% | 100.00% |
| July 3, 2024 | Fulcrum Therapeutics, Inc. | $FULC | Sapir Alex | See Remarks | M | Common Stock | 150000 | $3.27 | 193,360.0000 | 61,310 | 345.94% | 100.00% |
| July 3, 2024 | Fulcrum Therapeutics, Inc. | $FULC | Sapir Alex | See Remarks | M | Stock option - Right to Buy | 150000 | $0.00 | 2,280,400.0000 | 61,310 | 6.17% | 100.00% |
| March 4, 2024 | Fulcrum Therapeutics, Inc. | $FULC | Sapir Alex | See Remarks | P | Common Stock | 43360 | $11.35 | 43,360.0000 | 61,310 | 9999.99% | 70.72% |